| International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 305 | 2015 |
| Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ... The Lancet Gastroenterology & Hepatology 3 (9), 626-634, 2018 | 128 | 2018 |
| Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study S Basili, V Raparelli, L Napoleone, G Talerico, GR Corazza, F Perticone, ... Official journal of the American College of Gastroenterology| ACG 113 (3 …, 2018 | 99 | 2018 |
| The immunological basis of liver allograft rejection V Ronca, G Wootton, C Milani, O Cain Frontiers in immunology 11, 565592, 2020 | 98 | 2020 |
| An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs HJ Cordell, JJ Fryett, K Ueno, R Darlay, Y Aiba, Y Hitomi, M Kawashima, ... Journal of hepatology 75 (3), 572-581, 2021 | 90 | 2021 |
| Serum albumin is inversely associated with portal vein thrombosis in cirrhosis S Basili, R Carnevale, C Nocella, S Bartimoccia, V Raparelli, G Talerico, ... Hepatology communications 3 (4), 504-512, 2019 | 71 | 2019 |
| Real-world experience with obeticholic acid in patients with primary biliary cholangitis D D’Amato, A De Vincentis, F Malinverno, M Viganò, D Alvaro, M Pompili, ... JHEP Reports 3 (2), 100248, 2021 | 54 | 2021 |
| Novel therapeutics for primary biliary cholangitis: toward a disease-stage-based approach HS Mousa, M Carbone, F Malinverno, V Ronca, ME Gershwin, ... Autoimmunity reviews 15 (9), 870-876, 2016 | 42 | 2016 |
| X chromosome contribution to the genetic architecture of primary biliary cholangitis R Asselta, EM Paraboschi, A Gerussi, HJ Cordell, GF Mells, RN Sandford, ... Gastroenterology 160 (7), 2483-2495. e26, 2021 | 35 | 2021 |
| Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis V Ronca, C Mancuso, C Milani, M Carbone, YH Oo, P Invernizzi Journal of Leucocyte Biology 108 (2), 659-671, 2020 | 34 | 2020 |
| Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach L Cristoferi, V Calvaruso, D Overi, M Viganò, C Rigamonti, E Degasperi, ... Hepatology 74 (3), 1496-1508, 2021 | 33 | 2021 |
| Organ restoration with normothermic machine perfusion and immune reaction A Parente, DC Osei-Bordom, V Ronca, MTPR Perera, D Mirza Frontiers in immunology 11, 565616, 2020 | 30 | 2020 |
| Prognostic models in primary biliary cholangitis L Cristoferi, A Nardi, V Ronca, P Invernizzi, G Mells, M Carbone Journal of autoimmunity 95, 171-178, 2018 | 28 | 2018 |
| Direct oral anticoagulants and advanced liver disease: a systematic review and meta‐analysis D Menichelli, V Ronca, A Di Rocco, P Pignatelli, G Marco Podda, CAR European Journal of Clinical Investigation 51 (3), e13397, 2021 | 25 | 2021 |
| New therapeutic targets in autoimmune cholangiopathies A Gerussi, M Lucà, L Cristoferi, V Ronca, C Mancuso, C Milani, D D'Amato, ... Frontiers in Medicine 7, 117, 2020 | 25 | 2020 |
| Clinical and prognostic implications of acute onset of autoimmune hepatitis: an Italian multicentre study P Muratori, M Carbone, G Stangos, L Perini, C Lalanne, V Ronca, ... Digestive and Liver Disease 50 (7), 698-702, 2018 | 25 | 2018 |
| Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation AJ Montano-Loza, V Ronca, M Ebadi, BE Hansen, G Hirschfield, S Elwir, ... Journal of hepatology 77 (1), 84-97, 2022 | 23 | 2022 |
| The human immune response to cadaveric and living donor liver allografts A Hann, DC Osei-Bordom, DAH Neil, V Ronca, S Warner, MTPR Perera Frontiers in immunology 11, 1227, 2020 | 23 | 2020 |
| Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets M Carbone, C Milani, A Gerussi, V Ronca, L Cristoferi, P Invernizzi Journal of Hepatology 73 (4), 965-966, 2020 | 21 | 2020 |
| Primary sclerosing cholangitis: burden of disease and mortality using data from the national rare diseases registry in Italy M Carbone, Y Kodra, A Rocchetti, V Manno, G Minelli, A Gerussi, V Ronca, ... International journal of environmental research and public health 17 (9), 3095, 2020 | 21 | 2020 |
